Federated Hermes, Inc. Magenta Therapeutics, Inc. Transaction History

Federated Hermes, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.97 - $3.08 $192,143 - $610,104	-198,086 Reduced 51.13%	189,312 $227,000
Q1 2022 May 13, 2022	BUY	$2.55 - $5.23 $342,421 - $702,300	134,283 Added 53.05%	387,398 $1.12 Million
Q4 2021 Feb 14, 2022	BUY	$4.43 - $8.33 $161,119 - $302,962	36,370 Added 16.78%	253,115 $1.12 Million
Q3 2021 Nov 15, 2021	SELL	$6.07 - $9.89 $5,086 - $8,287	-838 Reduced 0.39%	216,745 $1.58 Million
Q2 2021 Aug 16, 2021	BUY	$9.76 - $14.15 $1.13 Million - $1.65 Million	116,280 Added 114.78%	217,583 $2.13 Million
Q1 2021 May 13, 2021	BUY	$7.66 - $13.38 $740,070 - $1.29 Million	96,615 Added 2060.9%	101,303 $1.2 Million
Q4 2020 Feb 12, 2021	BUY	$6.1 - $7.94 $2,562 - $3,334	420 Added 9.84%	4,688 $37,000
Q2 2020 Aug 13, 2020	SELL	$6.18 - $10.76 $1,637 - $2,851	-265 Reduced 5.85%	4,268 $32,000
Q1 2020 May 13, 2020	SELL	$6.03 - $15.24 $1,350 - $3,413	-224 Reduced 4.71%	4,533 $28,000
Q4 2019 Feb 14, 2020	SELL	$9.07 - $15.84 $9,877 - $17,249	-1,089 Reduced 18.63%	4,757 $72,000
Q3 2019 Nov 14, 2019	BUY	$9.63 - $14.0 $20,483 - $29,778	2,127 Added 57.19%	5,846 $60,000
Q2 2019 Aug 14, 2019	BUY	$13.4 - $17.67 $49,834 - $65,714	3,719 New	3,719 $55,000

442K

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.